CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $61,000 | -17.6% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $74,000 | -12.9% | 26,000 | -12.8% | 0.00% | 0.0% |
| Q3 2017 | $85,000 | +3.7% | 29,800 | -9.7% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | -32.8% | 33,000 | -2.7% | 0.00% | -50.0% |
| Q1 2017 | $122,000 | -10.3% | 33,900 | -11.5% | 0.00% | 0.0% |
| Q4 2016 | $136,000 | -9.3% | 38,300 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $150,000 | – | 37,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |